Refractory Ewing Sarcoma

DrugDrug NameDrug Description
DB00853TemozolomideAn alkylating agent used to treat glioblastoma multiforme and refractory anaplastic astrocytoma.
DrugDrug NameTargetType
DB00853TemozolomideDNAtarget
DrugDrug NamePhaseStatusCount
DB08875Cabozantinib2Recruiting1
DB14860Ensartinib2Recruiting1
DB12147Erdafitinib2Recruiting1
DB15127Hydrogen2Recruiting1
DB14568Ivosidenib2Not Yet Recruiting1
DB12167LY-30234142Recruiting1
DB14723Larotrectinib2Recruiting1
DB06075Linsitinib2Completed1
DB09074Olaparib2Recruiting1
DB09073Palbociclib2Recruiting2
DB11689Selumetinib2Recruiting1
DB14546Sulfate ion2Recruiting1
DB12887Tazemetostat2Recruiting1
DB13930Ulixertinib2Recruiting2
DB08881Vemurafenib2Recruiting1
DB13104X-3962Recruiting1